Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
INC056
- Development stage
- Phase 3
- Lead developer
- Incrementha PD&I
- Modality
- Small Molecules
- Administration
- Vaginal
01
Overview
INC056 is a non-hormonal intravaginal product developed by Incrementha PD&I, a Brazilian innovation center established as a joint venture between Eurofarma and Biolab. The product is currently in Phase III clinical development for the treatment of vaginal dryness and local irritation, symptoms commonly associated with vulvovaginal atrophy and menopause. INC056 is designed to provide a safe and effective alternative to estrogen-based therapies, focusing on restoring vaginal moisture and improving tissue tolerability. Clinical trials in Brazil have evaluated its efficacy and safety profile in comparison to established non-hormonal moisturizers, such as polycarbophil-based gels.
Beyond the preview
Go deeper on INC056.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on INC056.